


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.08%
+0.44%
-0.26%
-8.24%
-9.34%
SIGI
Selective Insurance
$81.35
Strengths

Earnings are forecast to grow

Trading below its fair value
Technical Indicators

Oversold
SIGI Price Performance
$85.62 (-4.99%)
$77.26 (+5.29%)
$79.04 (+2.92%)
$85.46 (-4.81%)
SIGI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Has a weak balance sheet

Reported a strong earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
SIGI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SIGI Street Sentiment is extremely bullish and have positive views on the near-term outlook
SIGI has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Low volume

Average key support and resistance price levels
What is SIGI current stock price?
What are SIGI stock strengths?
What is SIGI Risk Level?
What is SIGI market cap and volume?
What is SIGI current Stock IQ?
Should I buy SIGI stock right now?
Is SIGI a Strong Buy right now?
What does a 'Strong Buy' rating mean for SIGI?
What does a 'Strong Sell' rating mean for SIGI?
What factors influence SIGI's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.08%
+0.44%
-0.26%
-8.24%
-9.34%
SIGI
Selective Insurance
Current Price
$81.35
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value
Technical Indicators

Oversold

SIGI Price Performance
$85.62 (-4.99%)
$77.26 (+5.29%)
$79.04 (+2.92%)
$85.46 (-4.81%)
SIGI Analysts Opinion
SIGI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Has a weak balance sheet

Reported a strong earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
SIGI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SIGI Street Sentiment is extremely bullish and have positive views on the near-term outlook
SIGI has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Low volume

Average key support and resistance price levels
SIGI Stock IQ
SIGI Latest Analysis
Market Trading Guide: Buy Hindustan Zinc &. a midcap stock for up to 8% gains. Sell recommendation on Fortis Healthcare . Benchmark Nifty fell sharply for a second day amid tariff and geopolitical worries. Technicals stay bearish near oversold levels as the index drifts toward 200-DMA while analysts flag fragile support and selective stock opportunities ahead now.
Tue Jan 20, 2026
Press Release: Myqorzo and Redemplo approved in China. Myqorzo and Redemplo approved in ChinaParis January 15 2026. The National Medical Products Administration in China has approved two Sanofi-licensed innovative medicines Myqorzo (aficamten) for the treatment of obstructive hypertrophic cardiomyopathy (oHCM) and Redemplo (plozasiran) for the reduction of triglyceride levels in adult patients with familial chylomicronaemia syndrome (FCS) on the basis of dietary control. We are pleased to bring
Thu Jan 15, 2026
After blockbuster 2025 metal stocks tumble up to 10% weekly this year. Whats ahead? . Metal stocks experienced a dip in early 2026 with some declining up to 10% due to profit-booking and US tariff concerns. Despite this market experts highlight strong sector fundamentals and favorable momentum suggesting selective stock picking for potential upside. The Nifty Metal index saw a 3% weekly decline though some analysts remain positive on the long-term outlook.
Mon Jan 12, 2026
Market Trading Guide: Buy Eicher Motors Motherson Sumi &. 3 stocks on Tuesday for up to 15% gains . Markets ended lower as Nifty slipped amid IT and energy weakness but analysts see healthy consolidation above key supports. Experts suggest selective stock picking highlighting five technical buy ideas with defined targets stop losses and near-term upside potential ahead soon.
Mon Jan 5, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SIGI Stock trends
SIGI Stock performance
SIGI Stock analysis
SIGI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.